Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus that causes coronavirus disease 2019 (COVID-19), has caused…
The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and…
Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding…
In a cohort of BNT162b2 (Pfizer–BioNTech) mRNA vaccine recipients (n= 1,090), we observed that spike-specific IgG antibody levels…
During a pandemic, there are many situations in which the first available vaccines may not have as high…
As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for…
We report 23 women with axillary adenopathy on breast imaging after recent coronavirus disease (COVID-19) vaccination. A total…
Reports of patients with axillary adenopathy identified on breast imaging after coronavirus disease (COVID-19) vaccination are rising. We…
Now that COVID-19 vaccines are being rolled out, policymakers are wrestling with the question of how to distribute…
OnDecember11,2020, theUSFoodandDrugAdministration(FDA) issued an Emergency Use Authorization (EUA) for the Pfizer- BioNTech coronavirus disease 2019 (COVID-19) vaccine, administered…
In this small study involving older adults, adverse events associated with the mRNA-1273 vaccine were mainly mild or…
Antigens displayed on self-assembling nanoparticles can stimulate strong immune responses and have been playing an increasingly prominent role…
SARS-CoV-2 spike probes are key to antibody discovery and vaccineevaluation. By using structure-based design, affinity purification, on-column biotinylation,…
SARS-CoV-2 poses a public health threat for which therapeutic agents are urgently needed. Herein, we report that high-throughput…
The safety and immunogenicity data from this U.S. phase 1 trial of two vaccine candidates in younger and…
A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older.…
The distribution of target groups at country and regional levels highlights the importance of designing an equitable and…
Early in the covid-19 pandemic it was unclear whether and how individuals and populations would develop protective and…
The Indian manufacturer of the Oxford-AstraZeneca candidate vaccine against covid-19 (the Serum Institute of India) has threatened to…